Published in FDA Law Weekly, December 16th, 2004
"Using a bioassay-directed purification scheme, the active antibacterial principle from Caesalpina sappan was isolated and identified to be brazilin," wrote H.X. Xu and colleagues, Dalhousie University, Faculty of Dentistry.
The compound showed potent activity, with minimal inhibitory concentrations (MICs) ranging from 4 to 32 mcg/mL.
"[T]ime-kill studies showed that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.